CIM
ABBV icon

CIM Investment Management’s AbbVie ABBV Stock Holding History

CIM Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,099
Closed -$690K – 250
2021
Q4 		$690K Sell
5,099
-83
-2% -$9.8K 0.21% 99
2021
Q3 		$559K Sell
5,182
-27
-0.5% -$3.08K 0.18% 123
2021
Q2 		$587K Sell
5,209
-120
-2% -$13.5K 0.18% 118
2021
Q1 		$577K Sell
5,329
-179
-3% -$19.1K 0.18% 111
2020
Q4 		$590K Sell
5,508
-78
-1% -$7.5K 0.19% 104
2020
Q3 		$489K Sell
5,586
-54
-1% -$5.08K 0.19% 111
2020
Q2 		$554K Hold
5,640
– – 0.22% 99
2020
Q1 		$430K Buy
5,640
+182
+3% +$15.5K 0.21% 105
2019
Q4 		$483K Sell
5,458
-5,449
-50% -$452K 0.19% 121
2019
Q3 		$826K Sell
10,907
-1,103
-9% -$75.6K 0.31% 54
2019
Q2 		$873K Buy
12,010
+482
+4% +$37.9K 0.32% 59
2019
Q1 		$929K Buy
+11,528
New +$943K 0.36% 45
2017
Q2 		– Sell
-16,723
Closed -$1.09M – 358
2017
Q1 		$1.09M Sell
16,723
-1,500
-8% -$94.3K 0.37% 44
2016
Q4 		$1.14M Buy
18,223
+270
+2% +$16.5K 0.42% 42
2016
Q3 		$1.13M Sell
17,953
-1,250
-7% -$80.9K 0.43% 39
2016
Q2 		$1.19M Buy
19,203
+8,175
+74% +$498K 0.49% 42
2016
Q1 		$630K Sell
11,028
-1,167
-10% -$65K 0.27% 108
2015
Q4 		$722K Hold
12,195
– – 0.33% 109
2015
Q3 		$664K Hold
12,195
– – 0.32% 117
2015
Q2 		$819K Sell
12,195
-63
-0.5% -$4.11K 0.36% 105
2015
Q1 		$718K Hold
12,258
– – 0.31% 119
2014
Q4 		$802K Buy
+12,258
New +$773K 0.37% 102
2014
Q1 		– Sell
-21,285
Closed -$1.12M – 208
2013
Q4 		$1.12M Buy
21,285
+1,510
+8% +$74.2K 0.57% 64
2013
Q3 		$885K Hold
19,775
– – 0.52% 73
2013
Q2 		$817K Buy
+19,775
New +$865K 0.48% 77

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CIM Investment Management's ABBV Position: Q1 2022 in Review

CIM Investment Management sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 5,099 shares — an estimated $690K sold.

CIM Investment Management first reported a position in ABBV in Q2 2013 and held it in 25 quarters. The position peaked at $1.19M in Q2 2016. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • CIM Investment Management reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • CIM Investment Management sold 5,099 AbbVie shares in Q1 2022, an estimated $690K.
  • CIM Investment Management first reported a position in AbbVie in Q2 2013 and held it in 25 quarters.
  • CIM Investment Management's AbbVie position peaked at $1.19M in Q2 2016.
  • 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on CIM Investment Management's 13F filing for Q1 2022, filed 17 May 2022.